Back to Search Start Over

[Translated article] Trichotillomania Treatment Update.

Authors :
Nina Domínguez L
Imbernón-Moya A
Saceda-Corralo D
Vañó-Galván S
Source :
Actas dermo-sifiliograficas [Actas Dermosifiliogr] 2024 Nov 16. Date of Electronic Publication: 2024 Nov 16.
Publication Year :
2024
Publisher :
Ahead of Print

Abstract

Trichotillomania (TTM) is an obsessive-compulsive disorder in which affected individuals recurrently pull-out hair from any region of the body, causing hair loss or alopecia. The management of TTM is a therapeutic challenge for dermatologists and consists of a combination of pharmacological and non-pharmacological alternatives. Cognitive-behavioral therapy has successfully been used to treat TTM. However, not all patients are willing to follow this treatment strategy. Unconventional support tools are proposed, such as electronic devices, Internet therapies and microneedling. N-acetylcysteine and memantine are considered suitable first-line therapies thanks to their favorable safety and efficacy profile, low risk of adverse effects, and significant benefits. The use of other drugs, including fluoxetine, clomipramine, olanzapine, and naltrexone has limited evidence of variable efficacy. The present review illustrates the current treatment modalities for the management of TTM.<br />Competing Interests: Conflicts of interest None declared.<br /> (Copyright © 2024 AEDV. Publicado por Elsevier España, S.L.U. All rights reserved.)

Details

Language :
English; Spanish; Castilian
ISSN :
1578-2190
Database :
MEDLINE
Journal :
Actas dermo-sifiliograficas
Publication Type :
Academic Journal
Accession number :
39557288
Full Text :
https://doi.org/10.1016/j.ad.2024.11.014